FORM S-1

Company

NRX Pharmaceuticals, Inc.

Filed

November 14, 2024

Accession Number

0001437749-24-035167

An S-1 is a registration statement filed by a company preparing for its initial public offering (IPO). It discloses the business model, financials, risk factors, and use of proceeds. Learn more about S-1 filings →